Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis
- 25 September 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroimmune Pharmacology
- Vol. 6 (3), 354-361
- https://doi.org/10.1007/s11481-010-9243-6
Abstract
Glial activation in the setting of central nervous system inflammation is a key feature of the multiple sclerosis (MS) pathology. Monitoring glial activation in subjects with MS, therefore, has the potential to be informative with respect to disease activity. The translocator protein 18 kDa (TSPO) is a promising biomarker of glial activation that can be imaged by positron emission tomography (PET). To characterize the in vivo TSPO expression in MS, we analyzed brain PET scans in subjects with MS and healthy volunteers in an observational study using [11C]PBR28, a newly developed translocator protein-specific radioligand. The [11C]PBR28 PET showed altered compartmental distribution of TSPO in the MS brain compared to healthy volunteers (p = 0.019). Focal increases in [11C]PBR28 binding corresponded to areas of active inflammation as evidenced by significantly greater binding in regions of gadolinium contrast enhancement compared to contralateral normal-appearing white matter (p = 0.0039). Furthermore, increase in [11C]PBR28 binding preceded the appearance of contrast enhancement on magnetic resonance imaging in some lesions, suggesting a role for early glial activation in MS lesion formation. Global [11C]PBR28 binding showed correlation with disease duration (p = 0.041), but not with measures of clinical disability. These results further define TSPO as an informative marker of glial activation in MS.Keywords
This publication has 17 references indexed in Scilit:
- Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of NeuroinflammationJournal of Cerebral Blood Flow & Metabolism, 2010
- A review of graphical methods for tracer studies and strategies to reduce biasNuclear Medicine and Biology, 2003
- PET visualization of microglia in multiple sclerosis patients using [11C]PK11195European Journal of Neurology, 2003
- Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damageAnnals of Neurology, 2001
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithmIEEE Transactions on Medical Imaging, 2001
- The peripheral benzodiazepine binding site in the brain in multiple sclerosisBrain, 2000
- Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosisAnnals of Neurology, 1993
- Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1990